Ad Scientiam
VerifiedExploiting the immense potential of objective real-life data in patients to build new digital biomarkers.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$9—13m (Dealroom.co estimates Jul 2017.)
Company register number 795083336
Paris Île-de-France (HQ)
- hard tech
- biotechnology
- eit ecosystem
- observatoire deeptech
- eit health
- vivatech2019
- drug development
- biotech, medtech and e-health
- seal of excellence ec
- research and development
- digital pharma
- headstart (eit health)
- medical diagnostics
- headstart 2019 (eit health)
- go global (eit health)
- biomarkers
- bridgehead europe (eit health)
- go global 2018 (eit health)
- product market fit (eit health)
- product market fit 2018 (eit health)
- bridgehead europe 2018 (eit health)
| EUR | 2015 | 2016 |
|---|---|---|
| Revenues | 0000 | 0000 |
| % growth | - | 624 % |
| EBITDA | 0000 | 0000 |
| % EBITDA margin | (476 %) | (28 %) |
| Profit | 0000 | 0000 |
| % profit margin | (327 %) | 2 % |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | $0.0 | round |
| investor | $0.0 | round | |
| N/A | $0.0 | round | |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
€10.0k | Grant | ||
| Total Funding | 000k | ||
Related Content
Recent News about Ad Scientiam
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.